Search research articles
Contact Us
Filters
Showing results (121-130 of 145) with videos related to
Page
of 15
Sort By:
Nature Chemical Biology
|
August 11, 2014
A new mechanism of allostery in a G protein-coupled receptor dimer
J Robert Lane, Prashant Donthamsetti, Jeremy Shonberg, et al.
Journal of Medicinal Chemistry
|
January 20, 2023
Dopamine D<sub>3</sub>/D<sub>2</sub> Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Emma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, et al.
ACS Chemical Biology
|
July 25, 2019
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole
Carmen Klein Herenbrink, Ravi Verma, Herman D Lim, et al.
Nature Communications
|
February 25, 2016
The role of kinetic context in apparent biased agonism at GPCRs
Carmen Klein Herenbrink, David A Sykes, Prashant Donthamsetti, et al.
Biochemical Pharmacology
|
January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D<sub>2</sub> receptor
Christopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Science Signaling
|
May 25, 2017
Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2
Zil E Huma, Julie Sanchez, Herman D Lim, et al.
Journal of Medicinal Chemistry
|
May 20, 2021
Novel Dual-Target μ-Opioid Receptor and Dopamine D<sub>3</sub> Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management
Alessandro Bonifazi, Francisco O Battiti, Julie Sanchez, et al.
ACS Chemical Neuroscience
|
May 15, 2025
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D<sub>2</sub> Receptor
Herman D Lim, Damian Bartuzi, Alastair C Keen, et al.
Journal of Medicinal Chemistry
|
August 1, 2025
Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D<sub>3</sub> Dopamine Receptor
Amy E Moritz, Feijun Wang, Nora S Madaras, et al.
Scientific Reports
|
January 21, 2018
The action of a negative allosteric modulator at the dopamine D<sub>2</sub> receptor is dependent upon sodium ions
Christopher J Draper-Joyce, Ravi Kumar Verma, Mayako Michino, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 145) with videos related to
Sort By:
Page
of 15
Nature Chemical Biology
|
August 11, 2014
A new mechanism of allostery in a G protein-coupled receptor dimer
J Robert Lane, Prashant Donthamsetti, Jeremy Shonberg, et al.
Journal of Medicinal Chemistry
|
January 20, 2023
Dopamine D<sub>3</sub>/D<sub>2</sub> Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders
Emma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, et al.
ACS Chemical Biology
|
July 25, 2019
Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole
Carmen Klein Herenbrink, Ravi Verma, Herman D Lim, et al.
Nature Communications
|
February 25, 2016
The role of kinetic context in apparent biased agonism at GPCRs
Carmen Klein Herenbrink, David A Sykes, Prashant Donthamsetti, et al.
Biochemical Pharmacology
|
January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D<sub>2</sub> receptor
Christopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Science Signaling
|
May 25, 2017
Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2
Zil E Huma, Julie Sanchez, Herman D Lim, et al.
Journal of Medicinal Chemistry
|
May 20, 2021
Novel Dual-Target μ-Opioid Receptor and Dopamine D<sub>3</sub> Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management
Alessandro Bonifazi, Francisco O Battiti, Julie Sanchez, et al.
ACS Chemical Neuroscience
|
May 15, 2025
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D<sub>2</sub> Receptor
Herman D Lim, Damian Bartuzi, Alastair C Keen, et al.
Journal of Medicinal Chemistry
|
August 1, 2025
Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D<sub>3</sub> Dopamine Receptor
Amy E Moritz, Feijun Wang, Nora S Madaras, et al.
Scientific Reports
|
January 21, 2018
The action of a negative allosteric modulator at the dopamine D<sub>2</sub> receptor is dependent upon sodium ions
Christopher J Draper-Joyce, Ravi Kumar Verma, Mayako Michino, et al.
Page
of 15